TNF-Inhibition in the Treatment of Rheumatoid Arthritis - Softcover

Softcover

ISBN 10: 1841841560 ISBN 13: 9781841841564

Publisher: CRC Press, 2004

Synopsis

The introduction of tumor-necrosis-factor-alpha (TNFa) blocking agents is one of the milestones in the therapy of rheumatoid arthritis (RA). Edited by Larry Moreland and Paul Emery, experts in rheumatological disease, TNFa-Inhibition in the Treatment of Rheumatoid Arthritis charts the history and development of the concept of TNFa inhibition. The authors document TNFa from its discovery to its now well-documented clinical applications in the treatment of patients with RA. They compare and contrast practical management issues concerning the use of these agents both in the US and UK/Europe. The book is a practical and accessible source containing the most recent information in this field.

About this title

About the Author

Jacob Boe is Professor, Department of Thoracic Medicine, Rikshospitalet, Oslo, Norway. He is Past-President of the ERS and Co-Chairman of the ERS Nebulizer Task Force.

B. Ronan O'Driscoll, BSc, MD, FRCP, is Consultant Respiratory Physician, Cardiorespiratory Medicine, Hope Hospital, Salford, UK. He is Co-Chairman of the ERS Nebulizer Task Force. He has published several papers on clinical uses of nebulized therapy.

John H. Dennis, PhD, MSc, BSc, MBIOH, DipOccHyg is a Senior Lecturer in Occupational Hygiene and Pollution Science, Department of Environmental Medicine, University of Bradford, Bradford, UK. He is Co-Chairman of the ERS Nebulizer Task Force.

Edition details

• Publisher: CRC Press
• Publication date: 2004
• Language: English
• ISBN 10: 1841841560
• ISBN 13: 9781841841564
• Binding: Paperback
• Edition number: 1
• Number of pages: 192
• Editor: Moreland Larry W., Emery Paul